Clinical Trial
Accepted on 31 Jul 2025
Tegoprazan dual and quadruple therapy for Helicobacter pylori eradication: a prospective, randomized controlled trial in Beijing, China
in Gastroenterology
- 185 views
Clinical Trial
Accepted on 31 Jul 2025
in Gastroenterology
Original Research
Accepted on 31 Jul 2025
in Organizational Psychology
Original Research
Accepted on 31 Jul 2025
in Nutritional Immunology
Editorial
Accepted on 31 Jul 2025
in Orthopedic Surgery
Opinion
Accepted on 31 Jul 2025
in Signaling
General Commentary
Accepted on 31 Jul 2025
in Intestinal Microbiome
Original Research
Accepted on 31 Jul 2025
in Genomics of Plants and the Phytoecosystem
Original Research
Accepted on 31 Jul 2025
in Health and Cities
Original Research
Accepted on 31 Jul 2025
in Cancer Immunity and Immunotherapy
Systematic Review
Accepted on 31 Jul 2025
in Aging and Public Health
Original Research
Accepted on 31 Jul 2025
in Microbial Immunology
Original Research
Accepted on 31 Jul 2025
in Neuropsychology
Original Research
Accepted on 31 Jul 2025
in Health Economics
Original Research
Accepted on 31 Jul 2025
in Agroecology and Ecosystem Services
Review
Accepted on 31 Jul 2025
in Inflammation
Mini Review
Accepted on 31 Jul 2025
in Alzheimer's Disease and Related Dementias